Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
38 readers recommended
Experts addressed rising rates of cardiovascular disease in children with diabetes at EASD 2023, emphasizing prevention and finding new biomarkers for early...
156 readers recommended
New research from the ReTUNE study of people with type 2 diabetes at a normal weight by Dr. Roy Taylor, University of Newcastle, found that type 2 diabetes is not caused...
38 readers recommended
At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...
124 readers recommended
Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis.
94 readers recommended
The newest study of once-weekly insulins showed that insulin icodec led to similar reductions in A1C and similar time in range compared to once-daily Tresiba (degludec).
57 readers recommended
Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...
28 readers recommended
Here are our top stories from September 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.
48 readers recommended
People dealing with access to food are more likely to have overweight, obesity, or type 2 diabetes. If you face barriers to accessing nutritious foods, there are...
97 readers recommended
Early research finds that people with type 1 diabetes who started taking Ozempic (semaglutide) were able to reduce their insulin dose. This research suggests potential...
31 readers recommended
Oslo University conducts a global study investigating eating disorder prevention in type 1 diabetes. Join the study in the Pacific and Eastern time zones if you are...
84 readers recommended
Chronic kidney disease is a serious complication for people with diabetes. Recently approved in the U.S., Jardiance (empagliflozin) has been shown to significantly slow...
48 readers recommended
Join a study at UC San Diego investigating the potential benefits of the GLP-1 agonist semaglutide in non-alcoholic fatty liver disease (NAFLD).
51 readers recommended
Combat diabetes stigma and bullying at school by educating, planning, and seeking community support for a more inclusive environment.
49 readers recommended
Join clinical trial NCT05018585 investigating Diamyd's impact on people recently diagnosed with type 1 diabetes. The investigational drug could be a game-changer in...
161 readers recommended
Explore Vertex Pharmaceuticals’ trial l measuring the safety and effectiveness of VX-880 stem cell therapy in adults with type 1 diabetes. This trial is currently...
69 readers recommended
Diabetes technology revolutionizes type 1 diabetes management. Discover how CGMs and AID systems enhance glycemic control and ease daily burdens.
41 readers recommended
Explore the ACT1VATE trial on managing emotional distress in type 1 diabetes. Join a group or one-on-one virtual program to boost mental well-being and diabetes care...
49 readers recommended
New research reveals that individuals over 40 with type 2 diabetes taking statins may have a reduced risk of kidney disease. The study spans 21 years with 20,000...
40 readers recommended
Novo Nordisk's REDEFINE trials test CagriSema for weight and heart health in adults with type 2 diabetes and/or obesity. Participate and shape diabetes care.